Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study

BACKGROUND: Injectable daxibotulinumtoxinA (an investigational botulinum toxin, RT002) may offer a more prolonged duration of response—and therefore less frequent dosing—than onabotulinumtoxinA. OBJECTIVES: To perform a phase 2, open‐label, dose‐escalation study to assess the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankovic, Joseph, Truong, Daniel, Patel, Atul T., Brashear, Allison, Evatt, Marian, Rubio, Roman G., Oh, Chad K., Snyder, Daniel, Shears, Gill, Comella, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032882/
https://www.ncbi.nlm.nih.gov/pubmed/30009213
http://dx.doi.org/10.1002/mdc3.12613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032882/
https://www.ncbi.nlm.nih.gov/pubmed/30009213
http://dx.doi.org/10.1002/mdc3.12613

Ejemplares similares